Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00168883
Status:
UNKNOWN
Last Update Posted:
2006-11-01
First Post:
2005-09-09
Brief Title:
Study for Patients With Non Small Cell Lung Cancer NSCLC
Sponsor:
Charite University Berlin Germany
Organization:
Charite University Berlin Germany
Study Overview
Official Title:
Randomized Phase II Study to Determine the Efficacy of a Three Weekly vs Weekly Therapy With Paclitaxel Plus Carboplatin vs Paclitaxel Plus Vinorelbine for Patients With Non Small Cell Lung Cancer According to UICC Stage IIIB and IV
Status:
UNKNOWN
Status Verified Date:
2006-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized study to assess the efficacy and safety of chemotherapy with platin compared to chemotherapy without platin
Detailed Description:
Randomized Phase II design multicenter study to assess the efficacy and safety of combined chemotherapy with Paclitaxel and Carboplatin versus a platinum free chemotherapy with Paclitaxel and Vinorelbine within the combination therapies there are two different dosing intervals which will be assessed as well 4 Arm study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None